Advanced search
Publication Cover
The Journal of Maternal-Fetal & Neonatal Medicine Volume 31, 2018 - Issue 21
Submit an article Journal homepage
166
Views
0
CrossRef citations to date
0
Altmetric
Original Article

An evaluation of hearing in infants administered with colistin in the premature neonatal intensive care unit

Selman SarıcaKahramanmaras Sutcu Imam Universitesi Tip Fakultesi, Kahramanmaras, TurkeyCorrespondence[email protected]
ORCID Iconhttp://orcid.org/0000-0003-4246-8595
ORCID Icon &
Sadık YurttutanKahramanmaras Sutcu Imam Universitesi Tip Fakultesi, Kahramanmaras, Turkey
Pages 2918-2922 | Received 03 Nov 2017, Accepted 17 May 2018, Published online: 07 Jun 2018

References

  • Waissbluth S, Peleva E, Daniel SJ. Platinum-induced ototoxicity: a review of prevailing ototoxicity criteria. Eur Arch Otorhinolaryngol. 2017;274:1187–1196.
  • Markantonis SL, Markou N, Fousteri M, et al. Penetration of colistin into cerebrospinal fluid. Antimicrob Agents Chemother. 2009;53:4907–4910.
  • Livermore DM. Bacterial resistance: origins, epidemiology, and impact. Clin Infect Dis. 2003;36:S11–S23.
  • Kwa A, Kasiakou SK, Tam VH, et al. Polymyxin B: similarities to and differences from colistin (polymyxin E). Expert Rev Anti Infect Ther. 2007;5:811–821.
  • Bergen PJ, Landersdorfer CB, Zhang J, et al. Pharmacokinetics and pharmacodynamics of ‘old. Diagn Microbiol Infect Dis. 2012;74:213–223.
  • Giamarellou H. Multidrug-resistant gram-negative bacteria: how to treat and for how long. Int J Antimicrob Agents. 2010;36:S50–S54.
  • Lim LM, Ly N, Anderson D, et al. Resurgence of colistin: a review of resistance, toxicity, pharmacodynamics, and dosing. Pharmacotherapy 2010;30:1279–1291.
  • Boisson M, Gregoire N, Couet W, et al. Colistin in critically ill patients. Minerva Anestesiol. 2013;79:200–208.
  • Şua S, Dikici N. Kolistin. Yoğun Bakim Derg. 2010;30:1279–1291.
  • Park YH. Stem cell therapy for sensorineural hearing loss, still alive? J Audiol Otol. 2015;19:63–67.
  • Seligmann H, Podoshin L, Ben-David J, et al. Drug-induced tinnitus and other hearing disorders. Drug Saf. 1996;14:198–212.
  • Camacho-Gonzalez A, Spearman PW, Stoll BJ. Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin North Am. 2013;60:367–389.
  • Tsai MH, Chu SM, Hsu JF, et al. Risk factors and outcomes for multidrug-resistant gram-negative bacteremia in the NICU. Pediatrics 2014;133:e322–e329.
  • Isturiz R. Global resistance trends and the potential impact on empirical therapy. Int J Antimicrob Agents 2008;32:S201–S206.
  • Giske CG, Monnet DL, Cars O, et al. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob Agents Chemother. 2008;52:813–821.
  • Nation RL, Li J. Colistin in the 21st century. Curr Opin Infect Dis. 2009;22:535–543.
  • Berlana D, Llop JM, Fort E, et al. Use of colistin in the treatment of multiple-drug-resistant gram-negative infections. Am J Health Syst Pharm. 2005;62:39–47.
  • Akyıldız N. Kulak Hastalıkları Ve Mikrocerrahisi. Bk. 2. Ankara: Bilimsel Tıp Yayınevi; 2002.
  • Hall JW, 3rd, Baer JE, Chase PA, et al. Clinical application of otoacoustic emissions: what do we know about factors influencing measurement and analysis? Otolaryngol Head Neck Surg. 1994;110:22–38.
  • Plinkert PK, Bootz F, Vossieck T. Influence of static middle ear pressure on transiently evoked otoacoustic emissions and distortion products. Eur Arch Otorhinolaryngol. 1994;25:95–99.
  • Roland JT, Cohen NL. Vestibular and auditory oto-toxicity. In: Cummings CW, Fredrickson JM, Harker LA, et al., editors. Otolaryngology Head & Neck Surgery. 3rd ed. Vol. 4. St. Louis: Mosby-Year Book; 1998. p. 3186–3197.
  • Priuska EM, Schacht J. Mechanism and prevention of aminoglycoside ototoxicity: outer hair cells as targets and tools. Ear Nose Throat J. 1997;76:164–166, 168, 170.
  • Koch-Weser J, Sidel VW, Federman EB, et al. Adverse effects of sodium colistimethate. Ann Intern Med. 1970;72:857–868.
  • Campbell KC, Durrant J. Audiologic monitoring for ototoxicity. Otolaryngol Clin North Am. 1993;26:903–914.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.